Immunotherapy for the Treatment of Breast Cancer: Emerging New Data
Lida A Mina,1 Shannon Lim,2 Shakeela W Bahadur,1 Abdul T Firoz3 1Hematology Oncology Department, Banner MD Anderson Cancer Center, Gilbert, AZ, USA; 2Pharmacy Department, Banner MD Anderson Cancer Center, Gilbert, AZ, USA; 3Science Department, Arizona State University, Tempe, AZ, USACorrespondence:...
Saved in:
Main Authors: | Mina LA, Lim S, Bahadur SW, Firoz AT |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/f81b79e0b475402abd9d4701e7b12d30 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opportunities for metastatic triple negative breast cancer therapy
by: Inna P. Ganshina, et al.
Published: (2021) -
Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
by: Mai F. Tolba, et al.
Published: (2021) -
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
by: Ayoub NM, et al.
Published: (2019) -
The phenomenon of pseudoprogression in cancer immunotherapy: is everything so unambiguous?
by: Vladislav O. Sarzhevskiy, et al.
Published: (2021) -
Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
by: Pei-Yi Chu, et al.
Published: (2021)